More Drug Coverage Denials; New 5-Year Survival in Liver Cancer; Dx in a NUTshell

(Medage today) – Rejection of coverage for prescription drugs have increased among the main insurers, according to an examination of 4 billion requests. (New York Times) Sobi has announced the approval of the FDA of the Avrombopag (Doptelet) to treat thrombocytopenia in pediatrics …